Professor Sarath Ranganathan
Role:
Group Leader
Available for Student Supervision
You are here
Professor Sarath Ranganathan
Biography:
Associate Professor Sarath Ranganathan is a full-time specialist in paediatric respiratory medicine and director of a clinical department. He has published 64 papers in the past five years and has raised more than $10 million dollars in current funding. He has published technical and methodological papers in relation to the development of complex pulmonary function techniques for use in infants and young children, and is considered internationally to be an expert in the field of clinical respiratory physiology and early lung disease. He has delivered 18 guest lectures at international meetings over the past five years on this topic.
Other Affiliations:
- Director of Respiratory Medicine, Royal Children's Hospital
- Principal Fellow, Department of Paediatrics, University of Melbourne
Awards:
- 2016: Governor General’s Patron Award 2016 – AREST CF
- 2011-2014: Chair of the Joint American Thoracic Society /European Respiratory Society Working Group for Infant and Pre-school Pulmonary Function
- 2008- 2013: Member of the Research Advisory Committee of the Royal Australasian College of Physicians
- 2001: Developed the Paediatric Curriculum for Advanced Training in Respiratory Paediatrics
- 2007- 2010: Member of the Editorial Board, Am J Respir Crit Care Med
- Since 2010: Member of the Program Committee of the Pediatric Assembly, American Thoracic Society
- 2000: British Paediatric Respiratory Society Award
- 2001: British Paediatric Respiratory Society Award
- 2001: Cystic Fibrosis Trust UK Research Award
Research:
Associate Professor Sarath Ranganathan is co-director of an international collaborative research program called the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) which aims to develop new paradigms for treatment of children with this condition.
He is also a Principal Investigator of two other major research programs (the Barwon Infant Study and the Longitudinal Study of Australian Children), aiming to evaluate factors associated with early lung development and the evolution of chronic, non-communicable respiratory disorders in childhood.
Projects:
- AREST CF Studies:
- Detection of Early Lung Disease in Cystic Fibrosis
- Early Predictors and Improved Surveillance of Lung Disease in Cystic Fibrosis
- COMBAT CF: A phase 3 multi-centre randomised placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis
- Viral Pathogenesis of Early Cystic Fibrosis Lung Disease - The Barwon Infant Study
- Longitudinal study of Australian Children
- Health Implications for Young Adults Conceived Following Assisted Reproductive Technologies (iyags)
Sly PD, Chen L, Gangell C, Mott L, Murray C, Ranganathan SC and Stick S. Predicting the onset of bronchiectasis in infants and young children with cystic fibrosis. New Engl J Med 2013;368:1963-70
Ranganathan S, Skoric B, Ramsay KA, Carzino R, Gibson AM, Hart E, Harrison J, Bell SC and Kidd TJ. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Annals of the American Thoracic Society 2013 Ann Am Thorac Soc. 2013;10(2):108-14
Martin B, Schechter M, Copper P, Bell S, Jaffe A and Ranganathan S. A comparison of health measures recorded in the United States and Australian National Cystic Fibrosis Data Registries and the impact of newborn screening. Pediatrics 2012;129(2):e348-55)
Pillarisetti N, Williamson E, LinnaneB, Skoric B, Robertson C, Robinson P, Massie J, Hall GL, Sly P, Stick S and Ranganathan S. Infection, inflammation and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med Apr 2011; 184:75-81
Ranganathan S, Parsons F, Gangell C, Brennan S, Stick S and Sly P.Evolution of pulmonary inflammation and nutritional status in infants and young children with CF. Thorax 2011 May;66(5):408-413
Sly PD, Brennan S, Gangell C, Murray C, Mott L, Stick S, Conlan S, Robinson PJ, Robertson C andRanganathan S. Lung Disease at Diagnosis in Infants with Cystic Fibrosis following Newborn Screening. Am J Respir Crit Care Med 2009;180:146-52
Steinfort D, Wurzel D, Irving L and Ranganathan SC. Endobronchial ultrasound in pediatric pulmonology. Pediatric Pulmonology 2009;44:303-8
Ranganathan SC and Sonnappa S. Evidence based management of common respiratory disorders in childhood – pneumonia and other infections. Pediatr Clin North Am 2009;56: 135-156
Linnane B, Robertson C, Robinson P, Stick S, Sly P, Hall G, Brennan H, Nolan G, Franklin P and Ranganathan S. Lung function in infants with cystic fibrosis after diagnosis by newborn screening. Am J Respir Crit Care Med 2008;178:1238-1244
Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N and Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and TSPOT. TB in children. PLoS ONE 2008; 3(7): e2624. doi:10.1371/journal.pone.0002624*